Professional Documents
Culture Documents
Plasma Proteins
Although the proteins in all fluid compartments play a major physiologic
function, the plasma proteins are the most frequently analyzed. More than
500 plasma proteins have been identified. The properties of a few selected
plasma proteins are discussed here.
Prealbumin (Transthyretin)
Prealbumin is decreased in hepatic damage, acute phase inflammatory
response, and tissue necrosis. A low prealbumin level is also a sensitive
marker of poor protein nutritional status. When dietary intake of proteincalories is deficient, hepatic synthesis of proteins is reduced and
catabolism increases. This results in a decrease in the level of the proteins
originating in the liver, including prealbumin, albumin, and globulins
such as transferrin and complement C3. Prealbumin, because of its short
half-life of approximately 2 days, will decrease more rapidly than the other
proteins. Prealbumin is increased in patients receiving steroids, in
alcoholism, and in chronic renal failure.
Albumin
Decreased concentrations of serum albumin may be caused by the
following:
An inadequate source of amino acids, which is seen in malnutrition and
muscle-wasting diseases.
Liver disease, resulting in the inability of hepatocytes to synthesize
albumin. The increase in globulins that occurs in early cirrhosis,
however, will balance the loss in albumin to give a total protein
concentration within acceptable limits. The decline in serum albumin
is insignificant in viral hepatitis.
Gastrointestinal loss as interstitial fluid leaks out in inflammation
and disease of the intestinal mucosa.
Globulins
1-Antitrypsin.
A deficiency of 1-Antitrypsin is associated with severe, degenerative,
emphysematous pulmonary disease. The lung disease is attributed to the
unchecked proteolytic activity of proteases from leukocytes in the lung
during periods of inflammation. Juvenile hepatic cirrhosis is also a
correlative disease in 1-Antitrypsin deficiency The protein is synthesized
but not released from the hepatocyte.
1-Fetoprotein.
Conditions associated with an elevated AFP level include spina bifida and
neural tube defects, atresia of the gastrointestinal tract, and fetal distress
in general. Its use in determining neural tube defects before term is an
important reason for its assay. It is also increased in ataxia-telangiectasia,
tyrosinosis, and hemolytic disease of the newborn. It is interesting that
maternal serum AFP is also increased in the presence of twins. Low levels of
maternal AFP indicate an increased risk for Down's syndrome and trisomy.
The normal time for screening is between 15 and 20 weeks gestational
age. The maternal AFP increases gradually during this period; therefore,
interpretation requires accurate dating of the pregnancy. Maternal AFP levels
are also affected by maternal weight, which reflects blood volume (inverse
relationship), race (10% higher in African Americans), and diabetes
(lowered value); therefore, test results need to be adjusted for these variables.
It has been found that reporting AFP in multiples of the median (MoM)
leads to good correlation with infant risk. MoM is calculated by dividing
the patient's AFP value by the median reference value for that gestational
age. Most screening programs use 2.0 MoM as the upper limit and 0.5
MoM as the lower limit for maternal serum AFP.
Serum levels of AFP can also be used as a tumor marker. High
concentrations of AFP are found in many cases of hepatocellular carcinoma
(approximately 80%) and certain gonadal tumors in .
1-Acid Glycoprotein (Orosomucoid).
Increased concentration of this protein is the major cause of an increased
glycoprotein level in the serum during inflammation. It is also increased
Ceruloplasmin.
Low concentrations of ceruloplasmin at birth gradually increase to adult
levels and slowly continue to rise with age. Adult females have higher
concentrations than males and pregnancy, inflammatory processes,
malignancies, oral estrogen, and contraceptives cause an increased serum
concentration.
Certain diseases or disorders are associated with low serum
concentrations. In Wilson's disease (hepatolenticular degeneration), an
autosomal recessive inherited disease, the levels are typically low (0.1
g/L). Total serum copper is decreased, but the direct reacting fraction is elevated and the urinary excretion of copper is increased. The copper is
deposited in the skin, liver, and brain, resulting in hepatic cirrhosis and
neurologic damage. Copper also deposits in the cornea, producing the
characteristic Kayser-Fleischer rings. Low ceruloplasmin is also seen in
malnutrition; malabsorption; severe liver disease; nephrotic syndrome; and
Menkes syndrome (kinky hair disease), in which a decreased absorption of
copper results in a decrease in ceruloplasmin.
2 Macroglobulin.
In nephrosis, the levels of serum 2-macroglobulin may increase as
much as 10 times because its large size aids in its retention. The protein is
also increased in diabetes and liver disease. Use of contraceptive
medications and pregnancy increase the serum levels by 20%.
Transferrin (Siderophilin).
The most common form of anemia is iron deficiency anemia, a
hypochromic, microcytic anemia. In this type of anemia, transferrin in
serum is normal or increased. A decreased transferrin level generally reflects
an overall decrease in synthesis of protein, such as seen in liver disease or
malnutrition, or it may be seen in protein-losing disorders such as
nephrotic syndrome. Transferrin, a negative acute phase protein, is also
decreased in inflammation. A deficiency of plasma transferrin may result in
the accumulation of iron in apoferritin or in histiocytes or it may precipitate
in tissue as hemosiderin. Patients with hereditary transferrin deficiencies
have been shown to have significant hypochromic anemia. An increase of
iron bound to transferrin is found in a hereditary disorder of iron
metabolism, hemochromatosis, in which excess iron is deposited in the
tissue, especially the liver and the pancreas. This disorder is associated with
bronze skin, cirrhosis, diabetes mellitus, and low plasma transferrin levels.
Hemopexin.
Increased concentrations are also found in diabetes mellitus, Duchennetype muscular dystrophy, and some malignancies, especially melanomas. In
hemolytic disorders, serum hemopexin concentrations decrease. Administration of diphenylhydantoin also results in decreased concentrations.
2-Microglobulin.
Elevated serum levels are the result of impaired clearance by the kidney or
overproduction of the protein that occurs in a number of inflammatory
diseases, such as rheumatoid arthritis and systemic lupus erythematosus.
In patients with human immunodeficiency virus, a high B2M level in the
absence of renal failure indicates a large lymphocyte turnover rate, which
suggests the virus is killing lymphocytes. B 2 M may sometimes be seen
on HRE but, because of its low concentration, it is usually measured by
immunoassay.
Fibrinogen.
Fibrinogen is one of the largest proteins in blood plasma. It is
synthesized in the liver, and it is classified as a glycoprotein because it
has considerable carbohydrate content. On plasma electrophoresis, fibrinogen is seen as a distinct band between the - and gamma globulins.
The function of fibrinogen is to form a fibrin clot when activated by
thrombin; therefore, fibrinogen is virtually all removed in the clotting
process and is not seen in serum.
Fibrinogen customarily has been determined as clottable protein.
Fibrinogen concentration is proportional to the time required to fort a
clot after the addition of thrombin to citrated plasma. Fibrin split products
(degradation products of fibrinogen and fibrin) are determined by
immunoassay methods such as radial immunodiffusion, nephelometry,
and radioimmunoassay
Fibrinogen is one of the acute-phase reactants, a term that refers to
proteins that are significantly increased in plasma during the acute
phase of the inflammatory process. Fibrinogen levels also rise with
pregnancy and the use of birth control pills. Decreased values generally
reflect extensive coagulation, during which the fibrinogen is consumed.
C-Reactive Protein.
C-Reactive protein (CRP) is synthesized in the liver and appears in the
blood of patients with diverse inflammatory diseases. CRP was so named
because it precipitates with the C substance, a polysaccharide of pneumococci. However, it was found that CRP rises sharply whenever there is
tissue necrosis, whether the damage originates from a pneumococcal
infection or some other source. This led to the discovery that CRP
recognizes and binds to molecular groups found on a wide variety of
bacteria and fungi. CRP bound to bacteria promotes the binding of
complement, which facilitates their uptake by phagocytes. This process of
protein coating to enhance phagocytosis is known as opsonization.
CRP is one of the first acute phase proteins to rise in response to
inflammatory disease. It is significantly elevated in acute rheumatic fever,
bacterial infections, myocardial infarcts, rheumatoid arthritis,
carcinomatosis, gout, and viral infections. CRP has also been recognized
as an independent risk factor in cardiovascular disease based on the
findings that atherothrombosis, in addition to being a disease of lipid
accumulation, also represents a chronic inflammatory process. Using the
hsCRP assay, levels of <1, 1-3, and >3 mg/L correspond to low-,
moderate- and high-risk groups for future cardiovascular events. Elevated
levels of CRP stimulate the production of tissue factor that initiates
coagulation, activates complement, and binds to LDL in the atherosclerotic
plaque; evidence that points to a causal relationship between CRP levels
and cardiovascular disease. Furthermore, interventions such as weight loss,
diet, exercise, and smoking cessation and administration of
pharmacologic agents such as statins all lead to both reduced CRP levels
and reduced vascular risk .
Immunoglobulins (Igs).
When a foreign substance (antigen) is injected into an animal (e.g.,
rabbit or goat), an antibody that will react with that antigen is
synthesized. This reaction is relatively specific; that is, the antibodies will
react specifically and selectively with the antigen used to raise them.
Proteins and polysaccharides are strong antigens. Antibodies can be raised
in rabbits and other animals to the human immunoglobulins as well as the
other serum proteins. These rabbit antihuman immunoglobulin antibodies
are used to detect and to quantitatively assay IgG, IgA, IgM, IgD, and IgE.